GC
ELAN icon

Guggenheim Capital’s Elanco Animal Health ELAN Stock Holding History

Guggenheim Capital’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$515K Sell
20,924
-42,007
-67% -$971K ﹤0.01% 1277
2026
Q1 		$1.51M Buy
62,931
+39,710
+171% +$971K 0.01% 811
2025
Q4 		$525K Buy
+23,221
New +$505K ﹤0.01% 1255
2023
Q4 		– Sell
-12,122
Closed -$136K – 1889
2023
Q3 		$136K Sell
12,122
-2,801
-19% -$32.5K ﹤0.01% 1782
2023
Q2 		$150K Sell
14,923
-3,591
-19% -$33.3K ﹤0.01% 1807
2023
Q1 		$174K Sell
18,514
-2,403
-11% -$28.3K ﹤0.01% 1824
2022
Q4 		$256K Buy
20,917
+7,407
+55% +$92.3K ﹤0.01% 1719
2022
Q3 		$168K Buy
13,510
+1,506
+13% +$26.3K ﹤0.01% 1814
2022
Q2 		$236K Sell
12,004
-569
-5% -$13.5K ﹤0.01% 1879
2022
Q1 		$328K Sell
12,573
-6,214
-33% -$165K ﹤0.01% 1834
2021
Q4 		$533K Buy
18,787
+7,839
+72% +$244K ﹤0.01% 1663
2021
Q3 		$349K Sell
10,948
-47,896
-81% -$1.61M ﹤0.01% 1873
2021
Q2 		$2.04M Buy
58,844
+49,766
+548% +$1.64M 0.01% 1086
2021
Q1 		$267K Sell
9,078
-2,173
-19% -$66.8K ﹤0.01% 1998
2020
Q4 		$345K Sell
11,251
-2,187
-16% -$66.7K ﹤0.01% 1778
2020
Q3 		$375K Sell
13,438
-8,483
-39% -$215K ﹤0.01% 1556
2020
Q2 		$470K Buy
+21,921
New +$484K ﹤0.01% 1462
2020
Q1 		– Sell
-13,167
Closed -$388K – 1889
2019
Q4 		$388K Buy
13,167
+685
+5% +$18.6K ﹤0.01% 1701
2019
Q3 		$332K Sell
12,482
-915
-7% -$27.4K ﹤0.01% 1804
2019
Q2 		$453K Buy
+13,397
New +$435K ﹤0.01% 1704

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Guggenheim Capital's ELAN Position: Q2 2026 in Review

Guggenheim Capital reduced its Elanco Animal Health (ELAN) stake by 67% in Q2 2026, selling an estimated $971K and leaving 20,924 shares worth $515K. The position accounts for ﹤0.01% of the portfolio, ranked #1277.

Guggenheim Capital first reported a position in ELAN in Q2 2019 and has held it in 20 quarters since. The position peaked at $2.04M in Q2 2021. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Guggenheim Capital held 20,924 shares of Elanco Animal Health worth $515K as of Q2 2026.
  • Guggenheim Capital sold 42,007 Elanco Animal Health shares in Q2 2026, an estimated $971K.
  • Elanco Animal Health made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1277 holding.
  • Guggenheim Capital first reported a position in Elanco Animal Health in Q2 2019 and has held it in 20 quarters since.
  • Guggenheim Capital's Elanco Animal Health position peaked at $2.04M in Q2 2021.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.